Get started
Author

Alice Gangloff

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
2010 · Wendy De Roock, Bart Claes, et al. · The Lancet Oncology · 2,201
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure
2007 · Dominique Thabut, Julien Massard, et al. · Hepatology · 284
Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic
2020 · J.-J. Tuech, A. Gangloff, et al. · Journal of Visceral Surgery · 140
PDF
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
2017 · David Sefrioui, France Blanchard, et al. · British Journal of Cancer · 127
PDF
Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer
2015 · David Sefrioui, Nasrin Sarafan-Vasseur, et al. · Digestive and Liver Disease · 74
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
2019 · Philippe Merle, Jean-Frederic Blanc, et al. · The Lancet. Gastroenterology & hepatology · 60
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial
2023 · Julien Taïeb, Olivier Bouche, et al. · JAMA Oncology · 50
PDF
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
2020 · Frederic Di Fiore, Olivier Bouché, et al. · Digestive and Liver Disease · 45
PDF
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)
2021 · David Sefrioui, Ludivine Beaussire, et al. · British Journal of Cancer · 39
PDF
Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer
2014 · Aude Di Fiore, Stéphane Lecleire, et al. · Digestive and Liver Disease · 35
Fully versus partially covered self-expandable metal stents in benign esophageal strictures
2014 · A. Gangloff, S. Lecleire, et al. · Diseases of the Esophagus · 28
CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts
2018 · Lucie Laurent, David Sefrioui, et al. · HPB · 21
PDF
Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study
2017 · Thomas Walter, David Malka, et al. · Digestive and Liver Disease · 20
Our challenge is to adapt the organization of our system to the six stages of the epidemic to go beyond the COVID-19 crisis
2020 · J J Tuech, A Gangloff, et al. · British journal of surgery · 19
PDF
Circulating DNA changes are predictive of disease progression after transarterial chemoembolization
2021 · David Sefrioui, Vincent Verdier, et al. · International Journal of Cancer · 16
PDF
Copy number variations in DCC/18q and ERBB2/17q are associated with disease‐free survival in microsatellite stable colon cancer
2016 · David Sefrioui, Thomas Vermeulin, et al. · International Journal of Cancer · 13
PDF
The Day after Tomorrow: How Should We Address Health System Organization to Treat Cancer Patients after the Peak of the COVID-19 Epidemic?
2020 · Jean-Jacques Tuech, Alice Gangloff, et al. · Oncology · 11
PDF
ctDNA variations according to treatment intensity in first-line metastatic colorectal cancer
2025 · Adrien Grancher, Ludivine Beaussire-Trouvay, et al. · British Journal of Cancer · 7
PDF
Stratégie pour la pratique de la chirurgie digestive et oncologique en situation d’épidémie de COVID-19
2020 · J.-J. Tuech, A. Gangloff, et al. · Journal de Chirurgie Viscérale · 6
PDF
1007P cfDNA and ctDNA variations are predictive of disease progression to conventional transarterial chemoembolization (cTACE) in patients with hepatocellular carcinoma (HCC)
2020 · D. Sefrioui, V. Verdier, et al. · Annals of Oncology · 2
Percutaneous Biliary External–Internal Drainage for Malignant Obstruction of Self-Expanding Uncovered Metal Stents Placed for Hilar Carcinoma: Retrospective Analysis of Long-Term Outcome in 160 Patients
2020 · Didier H. Bonnel, Alice Gangloff, et al. · Journal of Clinical Interventional Radiology ISVIR · 2
PDF
Clinical Interest of Digital Pcr for Routine Detection of Circulating Dna in Metastatic Colorectal Cancer
2014 · D. Sefrioui, C. Vasseur, et al. · Annals of Oncology · 2
Cancers de l'estomac
2013 · Alice Gangloff, Pierre Michel · 2
Analyse préliminaire des risques appliquée au parcours patient nécessitant une endoscopie digestive programmée sous anesthésie générale
2019 · Justine Thérin, Alice Gangloff, et al. · Le Pharmacien Hospitalier et Clinicien
Conception d’une application mobile d’aide à la prise en charge en hépato-gastroentérologie à destination des internes : le projet « GastroHelp »
2018 · Julien Lazartigues, Alice Gangloff, et al. · Hépato-Gastro & Oncologie Digestive
Works count: 34
Citation count: 3,204
H-index: 15
I10-index: 17
Year
Topic
Type